investorscraft@gmail.com

Femasys Inc. (FEMY)

Previous Close
$0.93
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)173.9518578
Intrinsic value (DCF)0.00-100
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

3950 Johns Creek Court
Suwanee, GA 30024
United States
Phone: 770 500 3910
Industry: Medical - Instruments & Supplies
Sector: Healthcare
CEO: Ms. Kathy Lee-Sepsick M.B.A.
Full Time Employees: 69

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

HomeMenuAccount